![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 47/64 | (2006.01) |
C07K 16/30 | (2006.01) | ||
C07K 16/36 | (2006.01) |
(11) | Number of the document | 2582728 |
(13) | Kind of document | T |
(96) | European patent application number | 11725095.1 |
Date of filing the European patent application | 2011-06-15 | |
(97) | Date of publication of the European application | 2013-04-24 |
(45) | Date of publication and mention of the grant of the patent | 2017-08-23 |
(46) | Date of publication of the claims translation | 2017-12-11 |
(86) | Number | PCT/EP2011/059917 |
Date | 2011-06-15 |
(87) | Number | WO 2011/157741 |
Date | 2011-12-22 |
(30) | Number | Date | Country code |
201161434776 P | 2011-01-20 | US | |
201100039 | 2011-01-20 | DK | |
354970 P | 2010-06-15 | US | |
201000529 | 2010-06-15 | DK |
(72) |
SATIJN, David, NL
VERPLOEGEN, Sandra, NL
BLEEKER, Wim, NL
LISBY, Steen, DK
WINKEL, Jan van de, NL
BERKEL, Patrick van, NL
PARREN, Paul, NL
|
(73) |
Genmab A/S,
Carl Jacobsens Vej 30, 2500 Valby,
DK
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Žmogaus antikūno vaisto konjugatai prieš audinių faktorių |
HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR |
Payment date | Validity (years) | Amount | |
2025-05-05 | 15 | 289.00 EUR |
2026-06-15 |